Lichen Planus (LP) is an infl ammatory chronic mucocutaneous disease. Since the etiology of OLP is unknown, efforts to understand the etiology and pathogenecity may lead to improve treatment modalities. Studies have shown the different levels of increase or decrease of various cytokines in saliva, serum or tissue culture of patients with OLP.As saliva originates from blood and its collection is an easy, non-invasive method, so it can be a diagnostic fl uid that has logistical advantages when compared with serum. The purpose of this study was to compare the salivary level of IL17 and IL22 in patients with and without OLP. Saliva of 52 patients with and without OLP was collected. The saliva level of IL17 and IL 22 was measured by using ELISA. Data were analyzed using independent T test, Mann-Whitney and Pearson Correlation test.The saliva concentration of IL 22 was significantly higher in control group than OLP but the difference was not signifi cant between reticular and atrophic-erosive type (P > 0.05).The difference between mean rank of IL17 for OLP and healthy cases and between reticular and erosive-atrophic form was not signifi cant (P > 0.05). There was no correlation between the level of IL17 and IL 22 (P > 0.05). Our fi ndings suggest that IL 22 may have an effect in the pathogenesis of OLP and its protective effect may be decreased in OLP patients.
INTRODUCTION
Lichen Planus (LP) is an infl ammatory chronic mucocutaneous disease that affects 1-2% of the general population, and is the non-infected mucosal disease causing the most referral to dental clinics (Pakfetrat et al. 2009 ). The oral cavity is the most common site of the disease. Oral Lichen Planus (OLP) usually affects middle aged women (30-60 years), children are rarely affected.World Health Organization (WHO) has considered OLP as a pre-cancerous disorder. Although OLP is considered an immunologically mediated disease, its etiology is not known, yet. The involvement of both specifi c and non-specifi c antigens are considered to have roles in pathogenesis of OLP (van der Meij et al. Aghahosseini et al. 2006 Pourshahidi et al. 2011; Agha-Hosseini et al. 2015) .
Alteration of the immune condition is not well known in OLP to date, but it is clear that cytokines exhibit immunoregulatory actions through a complex cytokine network consisting of paracrine and autocrine systems. Unbalanced cytokine actions are considered to play a role in the pathogenesis of autoimmune diseases. Numerous cytokines are secreted from oral mucosa or blood as locally or systemically that they have an important role in initiation and progression (courses) of OLP (Zhang et al. 2008) .
Increased production of cytokine by keratinocytes that may be the result of stimulation by external stimulants is the initial event. Then infi ltration of monocytes followed by lymphocytes could be the next step. Studies have shown the different levels of increase or decrease of various cytokines in saliva or serum or tissue culture of patients with OLP (Yamamoto et al. 1990; Rhodus et al. 2005; Zhang et al. 2008) .
Interleukin (IL) 17 A, also named IL17, is the most important IL from the IL17 family which is composed of 6 members (IL17A-IL17F). IL 22 is a member of IL10 family and it has a role in immune reaction against bacterial pathogens, especially in epithelium. IL17 and 22 are produced by T helper 17 and contribute in both innate and acquired immune responses against extra cellular pathogens (Lambiase et al. 2009 ). The role of Th17 and its cytokines (IL17 and 22) have been established in infl amed tissues in various autoimmune diseases such as psoriasis, multiple sclerosis, lupus erythematosus, rheumatoid arthritis, infl ammatory bowel disease (IBD) and pemphigus (Miossec et al. 2009 ).Saliva originates from blood. Saliva collection is an easy, noninvasive method, and it has been shown that various tumor markers are present in saliva. Therefore it can be a diagnostic fl uid that has logistical advantages when compared with serum (Agha-Hosseini et al. 2015) . The purpose of this study was to compare the level of IL17 and IL22 in saliva in patients with and without OLP.
MATERIAL AND METHODS
Fifty two samples of referred patients to the Department of Oral Medicine, Faculty of Dentistry, Tehran University of Medical Sciences included in this cross-sectional study (26 in each group).this study was approved by ethical committee and also all subjects provided written informed consent to participate in the study. OLP was diagnosed clinically and confi rmed histopathologically according to the modifi ed WHO criteria in 2003 as below:Clinical criteria: presence of symmetric or bilateral reticular or papular lesions with or without erosiveatrophic components. Histological criteria: presence of well-defi ned band-like zones of infl ammatory infi ltration confi ned to the superfi cial part of connective tissue, consisting mainly of mature lymphocytes; signs of "liquefaction degeneration" in basal cell layer, absence of epithelial dysplasia. Exclusion criteria: application of any local treatment for OLP lesions during the previous month; taking any drugs during the previous 3 months; history of allergy to foods or environmental factors, smoking; the existence of any oral lesions except OLP, systemic diseases (cardiovascular disease, kidney, hypertension), pregnancy. We also excluded patients whose lesion was nearby amalgam restorations. The unstimulated whole saliva (UWS) was collected between 10:00 a.m. and 12:00 p.m., and at least 90 minutes after the last intake of drink or food. All subjects were requested to swallow fi rst, tilt the head forward and then expectorate at least 5cc UWS into a sterile centrifugal tube without swallowing. The samples were centrifuged (2000g for 10 min), and the supernatants stored at -20 oC until analysis. The saliva level of IL was measured by using Enzyme-Linked Immunosorbent Assay (ELISA) kits, Human platiniumIL17A (BMS2017) and Human plutonium IL22 (88-7522-22) (bioscience, USA).
STATISTICAL ANALYSIS
Independent T test was used to compare the mean of IL22 between two groups; and Mann-Whitney for IL17. Pearson Correlation test was used for assessing the correlation between IL 17 and IL22 in each group. A P value less than 0.05 was considered statistically signifi cant and primary power of analysis was set at 80%.
RESULTS AND DISCUSSION
26 patients with OLP (22 females and 4 males) and 26 sex and aged matched healthy individuals were enrolled in this study. The mean age was 50.81±12.61 years, and 49.42±5.33 years in OLP and control groups respectively. 23% (6 patients) of OLP was reticular form, and 77% (20 patients) was atrophic-erosive form. The mean Shiva Shirazian et al.
of IL22 was 184.48±4.58 pg/ml in OLP and 209.01±4.58 pg/ml in control group, there was signifi cant difference between two groups (p=0.003). The mean of IL 22 was 176.5±9.40 pg/ml in reticular and 186.88±5.26 in atrophic-erosive type but the difference was not significant (p=0.35).
The mean of IL 17 was 5.24±2.709 pg/ml in OLP and 0.526±0.164 pg/ml in control. The mean rank of IL17 was 37.33 and 33.59 for OLP and healthy cases respectively. The difference was not signifi cant (p=0.436). The difference between the mean of IL17 in reticular and erosive-atrophic form was not signifi cant (p=0.25).
There was no correlation between the level of IL17 and IL22 (p=0.35, r=-0.19)in healthy patients. Although correlation analysis revealed no signifi cant correlation between IL17 and IL 22 in OLP group but it seems to be a reverse correlation between them according to the statistical fi ndings (p=0.054, r=-0.049).
As the etiology of OLP is unknown and because it is one of the most common lesion referred to dental clinics, studies on the pathogenesis of the OLP are of high importance. In this study we evaluated the relevance of IL17 and IL22 with OLP. The saliva concentration of Interleukin 22 was signifi cantly higher in control group than OLP but the difference was not signifi cant between reticular and atrophic-erosive type (P>0.05). We couldn't fi nd any studies on OLP patients' salivary levels of IL22. But Chen et al and Shen et al studied on IL22 in the tissue samples from OLP patients and found it more than their control group (Chen et al. 2011; Shen et al. 2012 ). More expression of IL22 in the tissue may be due to the location of its receptors which is on the epithelial origin cells (Ouyang et al. 2008 ). On the other hand there are some researches on the role of IL22 and psoriasis (Zheng et al. 2007; Lowes et al. 2008) . Zaba et al. (2007) in an animal study reported the higher expression of IL17 and IL22 in skin lesions of mice with psoriasis; but Zheng and Ma reported that defi ciency and limitation of IL22 can exaggerate skin lesion of psoriasis in mice (Zaba et al. 2007; Zheng et al. 2007; Ma et al. 2008 ). This controversy reveals that more studies should be done on the subject. The salivary level of IL17 in OLP patients of our study was higher than the control group but the difference was not statistically signifi cant (p=0.436). On the basis of our knowledge there is no study on salivary level of IL17 in OLP. Zhang et al. (2007) compared the level of IL1, IL8 and TNF in serum and saliva in 30 OLP patients and 30 healthy controls. These IL were higher signifi cantly in saliva and serum in patients than control, and the level of IL8 was higher in saliva in erosive OLP than other types (Zhang et al. 2008) . Xie et al. (2012) assessed Th1 and Th17 in tissue (by double immunofl uorescence staining) and in serum (by fl ow cytometry) of 40 patients with OLP (22 cases with reticular type and 18 cases with erosive-atrophic type). Their results showed that the Th17 and Th1 cells were similar in tissue, but both were increased in serum. Th17 was higher in erosive-atrophic OLP than reticular. The level of IL 17 was signifi cantly higher in serum of OLP patients than controls and in erosive-atrophic OLP than reticular.
The role of IL17 has been assessed in other autoimmune diseases in previous studies (Moseley et al. 2003; Nistala et al. 2009; Caproni et al. 2009). Caporni and evaluated the level of IL17 in serum of psoriasis patients before and after treatment, and compared with healthy controls. The level of IL17 was higher in patients than control and was reduced to a low level after treatment [21] . Ziolkowska et al measured the level of IL17 in serum and synovial fl uid of joints in 15 patients with rheumatoid arthritis, and compared with healthy controls. Their results showed higher level of IL17 in patients than control (Ziolkowska et al. 2000) . Zhao et al studied the role of Th17 in asthma sensitivity. Percentages of Th17 cells and the level of several cytokines including IL4, IL22, IL25, IL17 and INF were measured. Th17 cells and related cytokines had the most increasing; additionally, the amount of IL17 and IL22 and Th17 had a positive correlation with the severity of disease (Zhao et al. 2010) .
A hypersensitivity reaction is considered in pathogenesis of OLP when cytokines are released by activated T cell, resulting in accumulation of infl ammatory cells, and the destruction of keratinocytes due to the cytotoxicity of cells (Sezer et al. 2007) .
The immune mechanism with specifi c and non specifi c antigen are proposed in the pathogenesis of OLP (Sugerman et al. 2005) . IL17 may up regulate various cytokines like IL1, IL8 and TNF (Hwang et al. 2004 ). In the study of Zhang et al (2008) the serum and salivary level of these cytokines was elevated in OLP patients such as other studies (Sun et al. 2005; Rhodus et al. 2006; Janardhanam et al. 2007; Rhodus et al. 2007 ). Therefore, it may be postulated that IL17 probably has a role in pathogenesis of OLP by increasing these infl ammatory cytokines. In non specifi c antigen, another mechanism may be degranulation of mast cells and activation of MMP (Sugerman et al. 2005) . Jovanovic et al (2001) reported that IL17 acts as an up regulator of local infl ammatory factors, causing injury of extracellular matrix through MMP (in vitro). Therefore it may be an infl uence in pathogenesis of OLP. In present study the level of IL17 was ten times higher than the level of healthy control (5.24 pg/ml in patients and 0.516 pg/ ml in healthy subjects), although the difference was not signifi cant statistically.
It is clear that IL22 has protection effects while IL 17 has not (Zenewicz et al. 2007; Sonnenberg et al. 2010) . Consequently, with the lower level of IL22 and higher Shiva Shirazian et al.
level of other infl ammatory cytokines, epithelial cells are disposed to destroy, and OLP lesions can appear. This hypothesis of the reverse correlation between IL17 and IL22 in patients with OLP is strengthened, but it needs more research.
CONCLUSION
Our fi ndings suggest that IL 22 may have an effect in the pathogenesis of OLP and its protective effect may be decreased in OLP patients.
